Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,955 | 12,584 | 15,593 | 18,284 | 9,573 |
| Receivables | N/A | N/A | 233 | N/A | N/A |
| Other current assets | 933 | 499 | 329 | 404 | 683 |
| TOTAL | $10,888 | $13,083 | $16,155 | $18,687 | $10,256 |
| Non-Current Assets | |||||
| PPE Net | 766 | 838 | 887 | 919 | 1,008 |
| Other Non-Current Assets | 0 | 496 | 10 | 20 | 29 |
| TOTAL | $766 | $1,334 | $897 | $938 | $1,037 |
| Total Assets | $11,654 | $14,417 | $17,051 | $19,626 | $11,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 562 | 740 | 1,018 | 1,149 | 1,153 |
| Accrued Expenses | 1,211 | 1,008 | 1,041 | 901 | 1,273 |
| TOTAL | $4,045 | $4,801 | $4,965 | $4,954 | $5,330 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,179 | 2,905 | 2,905 | 2,905 | 2,905 |
| TOTAL | $N/A | $N/A | $726 | $1,453 | $2,179 |
| Total Liabilities | $4,045 | $4,801 | $5,691 | $6,407 | $7,509 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 675 | 675 | 663 | 645 | 644 |
| Common Shares | 70 | 70 | 69 | 534 | 283 |
| Retained earnings | -155,500 | -153,340 | -150,962 | -148,168 | -144,671 |
| TOTAL | $7,609 | $9,615 | $11,361 | $13,219 | $3,784 |
| Total Liabilities And Equity | $11,654 | $14,417 | $17,051 | $19,626 | $11,293 |